Jeuveau Powder
NDC Package 72301-595-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Jeuveau (prabotulinum toxin type a) powders is jEUVEAU is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients. This formulation utilizes a powder delivery system. Marketed by Evolus, Inc., this product is identified by NDC 72301-595 and is authorized under FDA application BLA761085.

Identification & Billing

NDC Package Code
72301-595-10
Package Description
1 VIAL in 1 CARTON / 1 POWDER in 1 VIAL
Product Code
72301-595
11-Digit Billing Format
72301059510
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Jeuveau
Non-Proprietary Name
Prabotulinum Toxin Type A
Substance Name
Botulinum Toxin Type A
Dosage Form
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Administration Route
Intramuscular - Administration within a muscle.
Active Ingredient(s)
BOTULINUM TOXIN TYPE A 100 [USP'U]/1
Pharmacologic Class
Usage Information
JEUVEAU is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients.

Regulatory & Marketing

Labeler Name
Evolus, Inc.
Product Type
Human Prescription Drug
FDA Application #
BLA761085
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
02-13-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72301-595-10 identifies a specific commercial package of 1 vial in 1 carton / 1 powder in 1 vial of Jeuveau, a human prescription drug labeled by Evolus, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This powder is formulated for intramuscular use and contains botulinum toxin type a as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Evolus, Inc. on February 13, 2019. The current certification is valid through December 31, 2026.

How is this Evolus, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72301059510. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72301-595-10
11-Digit CMS (5-4-2)
72301-0595-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.